Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PFE vs MRNA✓SelectedUSD · MRNAPFE vs MRNA performance historyLatest closeAs of-0.10%11/16
Stock and ETF performance explorer

PFE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1.8%
MRNA return
+878.5%
Excess return
-876.7%
Maximum drawdown
-59.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.1%-3.6%+3.5%+0.1%
7D-1.3%-20.0%+18.7%0.0%
30D-1.0%-1.3%+0.2%-1.2%
3M+9.3%+240.0%-230.7%-3.9%
6M+17.6%+339.0%-321.3%+0.3%
YTD+23.7%+630.0%-606.3%-0.6%
1Y+22.9%+769.1%-746.2%-3.1%
3Y+17.7%+181.2%-163.5%-0.2%
5Y-23.8%-8.1%-15.6%-31.7%
All+1.8%+878.5%-876.7%-25.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling